Related Experiment Videos
Gout: a review of its aetiology and treatment
1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. edmundli@cuhk.edu.hk
Insights
Gout management involves understanding hyperuricemia, the metabolic cause of gout. Effective treatment combines preventive measures and drug therapies for acute attacks and long-term uric acid reduction.
Area of Science:
- Rheumatology
- Metabolic Disorders
- Pharmacology
Background:
- Gout is a metabolic disorder characterized by hyperuricemia.
- Hyperuricemia often remains asymptomatic but can lead to gouty arthritis and urolithiasis.
- The risk of gout and kidney stones increases with hyperuricemia severity and duration.
Purpose of the Study:
- To review the current understanding of gout's causes.
- To outline effective management strategies for gout.
Main Methods:
- Comprehensive literature review of peer-reviewed publications.
- MEDLINE database search from 1965 to January 2004.
- Author-led study selection, data extraction, and evaluation.
Main Results:
- Acute gouty arthritis is effectively treated with anti-inflammatory drugs, corticosteroids, or colchicine.
- Prophylactic therapy, including low-dose colchicine, is effective between attacks.
- Long-term uric acid-lowering agents are recommended for recurrent attacks to prevent tophaceous gout.
Conclusions:
- Effective gout management requires understanding its causes.
- Preventive measures and appropriate drug treatments are crucial.
- A multi-faceted approach ensures better patient outcomes.
Objective:
To review the current understanding of the causes and the management of gout.
Data Sources:
Publications on all peer-review literature from MEDLINE from 1965 to January 2004.
Study Selection:
Selected and evaluated by the author.
Data Extraction:
Extracted and evaluated by the author.
Data Synthesis:
The underlying metabolic disorder in gout is hyperuricaemia. Most patients with hyperuricaemia remain asymptomatic throughout their lifetime. The phase of asymptomatic hyperuricaemia ends with the first attack of gouty arthritis or urolithiasis. The risk of gout and stone formation is increased with the degree and duration of hyperuricaemia. Drugs available for the treatment of acute gouty arthritis, such as non-steroidal anti-inflammatory drugs, selective cyclo-oxygenase 2 inhibitors, systemic corticosteroids, or colchicine, are effective. For periods between attacks, prophylactic therapy, such as low-dose colchicine, is effective. In those with recurrent attacks of more than two to three times yearly, a uric acid-lowering agent as a long-term therapy should be considered to avoid recurrence and the development of tophaceous gout.
Conclusions:
Effective management of gout can be achieved through better understanding of the causes of the condition, preventive measures as well as drug treatment.
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis II: Pathophysiology